1. AB0625 The Clinical Significance of Antiphospholipid Antibodies in Systemic Sclerosis: A Systematic Review and Meta-Analysis. (15th July 2016) Authors: Merashli, M.; Ames, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antibodies against HDL components improve the diagnostic accuracy between ischemic stroke or coronary artery disease and healthy controls when added to traditional cardiovascular risk factors. (August 2018) Authors: Batuca, J.; Amaral, M.; Favas, C.; Justino, G.; Papoila, A.; Ames, P.; Delgado Alves, J. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0318 The Significance of Antiphospholipid Testing in Multiple Sclerosis: Systematic Review and Meta Analysis. (15th July 2016) Authors: Merashli, M.; Ames, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The oxidized low-density lipoprotein/b2-glycoprotein I complex in rtherothrombosis. (August 2018) Authors: Ames, P.; Di Girolamo, G.; D'Andrea, G.; Iannaccone, L.; Lopez, L.; Margaglione, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗